|
Market Closed -
London S.E.
16:35:22 08/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 77.50 GBX | 0.00% |
|
+4.73% | -3.73% |
| 08-13 | EARNINGS AND TRADING: tinybuild sues Max Ent; Light Science loss grows | AN |
| 08-13 | Arecor Therapeutics plc Publishes Clinical Data for AT278 in Peer-Reviewed Journal | CI |
| Market Cap | 29.26M 39.64M 34.08M 32.06M 54.61M 3.76B 54.89M 380M 147M 1.92B 149M 146M 6.11B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 27.94M 37.85M 32.55M 30.62M 52.14M 3.59B 52.41M 363M 140M 1.83B 142M 139M 5.84B | EV / Sales 2026 * |
31.8x | EV / Sales 2027 * | 30.9x |
| Free-Float |
46.91% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| AREC | Delayed | |
Deutsche Boerse AG
| 6UI | Delayed | |
|
Börse Stuttgart
| 6UI | Delayed |
Last Transcript : Arecor Therapeutics plc
| 1 week | +4.73% | ||
| Current month | +4.73% | ||
| 1 month | +34.78% | ||
| 3 months | +12.32% | ||
| 6 months | +7.64% | ||
| Current year | -3.73% |
| 1 week | 73 |  | 80 |
| 1 month | 56.2 | | 80 |
| Current year | 55.27 | | 95 |
| 1 year | 55.27 | | 100 |
| 3 years | 35.4 | | 199 |
| 5 years | 35.4 | | 472 |
| 10 years | 35.4 | | 472 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sarah Howell
CEO | Chief Executive Officer | 51 | 12/04/2021 |
David J. Ellam
DFI | Director of Finance/CFO | - | 17/11/2024 |
Jan Jezek
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/2007 |
| Director | Title | Age | Since |
|---|---|---|---|
Sarah Howell
BRD | Director/Board Member | 51 | 12/04/2021 |
Mohammad Fazeli
BRD | Director/Board Member | 61 | 31/08/2017 |
Andrew Richards
CHM | Chairman | 66 | 12/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/05/26 | Free | Chief Executive Officer | 160,000 | 0.4238% | ||
| 20/05/26 | Free | Executive/Senior Manager | 95,000 | 0.2516% | ||
| 20/05/26 | Free | Chief Financial Officer | 105,000 | 0.2781% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +4.73% | +9.93% | -58.67% | 39.63M | |
| -0.82% | -3.77% | -2.49% | +14.92% | 48.41B | |
| -1.29% | -1.22% | +404.92% | +545.45% | 45.01B | |
| -3.20% | +0.33% | +38.11% | +21.39% | 44.07B | |
| -1.89% | -2.00% | +1.45% | +82.46% | 40.73B | |
| -1.72% | -2.61% | +13.09% | +42.33% | 33.21B | |
| -0.17% | +3.78% | - | - | 17.77B | |
| -0.07% | +1.32% | +20.08% | +117.95% | 16.5B | |
| -0.56% | -0.50% | +11.39% | +31.41% | 14.45B | |
| -2.68% | -0.56% | +73.31% | +40.56% | 13.77B | |
| Average | -1.24% | +0.36% | +63.31% | +93.09% | 27.4B | |
| Weighted average by Cap. | -1.54% | -0.74% | +85.03% | +132.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 878K 1.19M 1.02M 963K 1.64M 113M 1.65M 11.41M 4.41M 57.67M 4.47M 4.37M 184M | 1.05M 1.42M 1.22M 1.15M 1.96M 135M 1.97M 13.63M 5.27M 68.93M 5.34M 5.22M 219M |
| Net income | - | - |
| Net Debt | -1.32M -1.79M -1.54M -1.45M -2.46M -170M -2.48M -17.14M -6.63M -86.64M -6.71M -6.57M -276M | 3.2M 4.34M 3.73M 3.51M 5.98M 411M 6.01M 41.59M 16.09M 210M 16.29M 15.94M 669M |
Employees
33
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/09/26 | GBX 77.50 | 0.00% | 40,019 |
| 07/09/26 | GBX 77.50 | +1.31% | 43,023 |
| 04/09/26 | GBX 76.50 | +3.38% | 14,817 |
| 03/09/26 | GBX 74.00 | 0.00% | 8,450 |
| 02/09/26 | GBX 74.00 | 0.00% | 1,507 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.7750GBP
Average target price
2.755GBP
Spread / Average Target
+255.48%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AREC Stock
Select your edition
All financial news and data tailored to specific country editions
